ILIAS Biologics Inc.
PrivateLast Round
Series B
Sep 28, 2020
Total Funding Raised
$50.89M
Company Overview
ILIAS Biologics Inc. is a biotechnology company that develops exosome-based therapeutics for inflammatory and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ILIAS Biologics Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ILIAS Biologics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 28, 2020 | ||||
| Series A | May 1, 2018 |
ILIAS Biologics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KIWOOM Securities Co., Ltd. | Series B |
| Genie Asset Management | Series B |
| Meritz Securities Co., Ltd. | Series B |
| Timefolio Asset Management | Series A, Series B |
| Daedeok Venture Partners | Series A, Series B |
| HB Investment | Series A, Series B |
| Devsisters Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2024
Monthly visitors grew 95% MoM, reaching 3.7K.
- Sep 28, 2020
$21M round with participation from Devsisters Ventures and Genie Asset Management.
ILIAS Biologics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ILIAS Biologics Inc.'s valuation, stock price, and market status.